SUZANNE WETHEROLD: Open Payments
NPI 1710993431 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 14 payments from 7 companies in 2025. Trend: 2023 $244 · 2024 $475 · 2025 $335
Food & beverage: $315Education: $20
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Alnylam Pharmaceuticals Inc. | 2 | $71 |
| Novo Nordisk Inc | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: VYNDAQEL, Kerendia, ONPATTRO, Ozempic, LEQVIO, CONTRAVE, MOUNJARO.
Industry payments across TX — which companies pay providers there.
